Orange Book product · Brand (NDA)
DYAZIDE
HYDROCHLOROTHIAZIDE; TRIAMTERENE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE; TRIAMTERENE
Strength
25MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 016042
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1984MAXZIDEBrand (NDA)
NDA 019129 · AUROBINDO PHARMA USA
- 2025TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 214611 · MACLEODS PHARMS LTD
- 2022TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 216211 · RUBICON RESEARCH
- 2019TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 208358 · CADILA
- 2018TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 208360 · ZYDUS PHARMS
- 2011TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 201407 · LANNETT CO INC
- 1999TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 075052 · DURAMED PHARMS BARR
- 1998TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 071251 · APOTEX INC
- 1998TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074970 · ANI PHARMS
- 1997TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074857 · NOVARTIS
- 1997TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074821 · SANDOZ
- 1996TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074701 · PHARMOBEDIENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
